Your browser doesn't support javascript.
loading
A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel.
Chi, K N; Kheoh, T; Ryan, C J; Molina, A; Bellmunt, J; Vogelzang, N J; Rathkopf, D E; Fizazi, K; Kantoff, P W; Li, J; Azad, A A; Eigl, B J; Heng, D Y C; Joshua, A M; de Bono, J S; Scher, H I.
Afiliação
  • Chi KN; Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada kchi@bccancer.bc.ca.
  • Kheoh T; Janssen Research & Development, San Diego.
  • Ryan CJ; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco.
  • Molina A; Janssen Research & Development, Menlo Park.
  • Bellmunt J; Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston.
  • Vogelzang NJ; Comprehensive Cancer Centers of Nevada, Las Vegas.
  • Rathkopf DE; Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA.
  • Fizazi K; Groupe Uro-Genitologie, Institut Gustave Roussy, University of Paris Sud, Villejuif, France.
  • Kantoff PW; Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston.
  • Li J; Johnson & Johnson Medical China, Shanghai, China.
  • Azad AA; Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada.
  • Eigl BJ; Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada.
  • Heng DY; Tom Baker Cancer Center and University of Calgary, Calgary.
  • Joshua AM; Department of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Canada.
  • de Bono JS; Drug Development Unit, Division of Cancer Therapeutics/Clinical Studies, The Institute for Cancer Research and Royal Marsden Hospital, Sutton, UK.
  • Scher HI; Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA.
Ann Oncol ; 27(3): 454-60, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26685010
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article